All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

14

Reset

14 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • BCGPhase 38 trials

    ImmunityBio, Inc. · Non-muscle Invasive Bladder Cancer (NMIBC), Papillary-Only Non-muscle-invasive Bladder Cancer, Tuberculosis

  • MTBVACBBV169Phase 32 trials

    Biofabri, S.L · Tuberculosis, Tuberculosis (TB)

  • TB-PPDPurified Protein Derivative of TuberculinPhase 32 trials

    Chengdu CoenBiotech Co., Ltd · Tuberculosis, Latent Tuberculosis Infection

  • QuabodepistatOPC-167832, QBSPhase 31 trial

    Otsuka · Rifampicin-Resistant Pulmonary Tuberculosis, Multidrug-Resistant Pulmonary Tuberculosis

  • DelamanidPhase 22 trials

    WestVac Biopharma Co., Ltd. · Tuberculosis, Multidrug Resistant Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis

  • HRZERifampicin, Isoniazid, Pyrazinamide, Ethambutol combinationPhase 22 trials

    Thirty Respiratory Limited · Pulmonary Tuberculoses, Tuberculosis Meningitis

  • Alpe375Phase 21 trial

    BioVersys AG · Tuberculosis Meningitis

  • AlpE500Phase 21 trial

    BioVersys AG · Tuberculosis Meningitis

  • AlpE625Phase 21 trial

    BioVersys AG · Tuberculosis Meningitis

  • BNT164a1Phase 21 trial

    BioNTech SE · Tuberculosis

  • BNT164b1Phase 21 trial

    BioNTech SE · Tuberculosis

  • BTZ-043Phase 21 trial

    GSK · Tuberculosis

  • GSK3036656Phase 21 trial

    GSK · Tuberculosis

  • JDB0131Phase 21 trial

    WestVac Biopharma Co., Ltd. · Tuberculosis, Multidrug Resistant Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.